Cases & Deals

Celgene collaborates with GlobeImmune

Clients Celgene International, Inc.

Jones Day advised Celgene International, Inc., a multinational biopharmaceutical company, in connection with its worldwide strategic collaboration with and related equity investment in GlobeImmune, Inc., a company focused on the discovery, development and commercialization of multiple product candidates based on targeted molecular immunotherapy for the treatment of cancer.